Meridian Wealth Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$657K Hold
3,352
0.02% 444
2025
Q4
$582K Hold
3,352
0.02% 466
2025
Q3
$639K Sell
3,352
-1
-0% -$177 0.02% 423
2025
Q2
$602K Hold
3,353
0.03% 404
2025
Q1
$567K Buy
3,353
+77
+2% +$12.6K 0.03% 387
2024
Q4
$494K Sell
3,276
-234
-7% -$36.4K 0.02% 407
2024
Q3
$545K Hold
3,510
0.03% 393
2024
Q2
$480K Buy
+3,510
New +$481K 0.06% 178
2024
Q1
Sell
-3,809
Closed -$525K 268
2023
Q4
$525K Buy
3,809
+12
+0.3% +$1.58K 0.03% 373
2023
Q3
$463K Buy
3,797
+1
+0% +$133 0.03% 381
2023
Q2
$534K Hold
3,796
0.05% 314
2023
Q1
$537K Buy
3,796
+1
+0% +$143 0.05% 303
2022
Q4
$594K Buy
3,795
+363
+11% +$52.2K 0.06% 278
2022
Q3
$421K Sell
3,432
-215
-6% -$28.3K 0.05% 304
2022
Q2
$485K Buy
3,647
+432
+13% +$58.9K 0.04% 356
2022
Q1
$440K Buy
3,215
+1
+0% +$139 0.05% 258
2021
Q4
$556K Sell
3,214
-103
-3% -$15.7K 0.06% 232
2021
Q3
$482K Hold
3,317
0.06% 227
2021
Q2
$438K Buy
3,317
+26
+0.8% +$3.4K 0.06% 248
2021
Q1
$422K Hold
3,291
0.06% 236
2020
Q4
$392K Buy
3,291
+117
+4% +$14.3K 0.06% 226
2020
Q3
$363K Buy
+3,174
New +$375K 0.09% 165

Other funds holding DGX

Meridian Wealth Management's DGX Position: Q1 2026 in Review

Meridian Wealth Management held its Quest Diagnostics (DGX) position steady in Q1 2026 at 3,352 shares worth $657K. The position accounts for 0.02% of the portfolio, ranked #444.

Meridian Wealth Management first reported a position in DGX in Q3 2020 and has held it in 22 quarters since. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Meridian Wealth Management held 3,352 shares of Quest Diagnostics worth $657K as of Q1 2026.
  • Meridian Wealth Management left its Quest Diagnostics share count unchanged in Q1 2026.
  • Quest Diagnostics made up 0.02% of Meridian Wealth Management's portfolio in Q1 2026, its #444 holding.
  • Meridian Wealth Management first reported a position in Quest Diagnostics in Q3 2020 and has held it in 22 quarters since.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Meridian Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.